Protagenic Therapeutics, Inc.\new Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
Protagenic Therapeutics, Inc.\new (PTIX) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 2.39% for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-05-15
- Protagenic Therapeutics, Inc.\new fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2018-03-31 was 2.39%.
- Protagenic Therapeutics, Inc.\new fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2016 was 1.93%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 0 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|
| 2018-03-31 | 2.39% 10-Q · filed 2018-05-15 | ||
| 2017-12-31 | 1.98% 10-Q · filed 2018-05-15 | ||
| 2016-12-31 | 1.93% 10-K · filed 2018-04-02 | ||
| 2016-02-12 | 1.20% 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |